A. W. Dekker - Concepedia

Author

A. W. Dekker

Also Known As

A W Dekker, A. W. Dekker, A.W Dekker, A.W. Dekker, ADRIAAN W. DEKKER, Adriaan Dekker, Adriaan W. Dekker, Adriaan Walter Dekker, Adriaan W. Dekker

Publications

Citations

H-Index

Concepts

All Affiliations

University Medical Center Utrecht Utrecht University Rotterdam University of Applied Sciences Erasmus University Rotterdam St. Antonius Ziekenhuis

About

A. W. Dekker is an author at University Medical Center Utrecht specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	18	898
2	Blood Transplantation	5	5	272
3	Health Sciences	4	4	128
4	Cellular Therapies	2	2	26
5	Gastroenterology	1	1	16

A. W. Dekker

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group. Bob Löwenberg, Stefan Suciu, E Archimbaud, Journal of Clinical Oncology	1998	288
Comparison of CHOP Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-Hodgkin's Lymphoma Leo F. Verdonck, Wim L.J. van Putten, Anton Hagenbeek, New England Journal of Medicine	1995	280
Infection Prophylaxis in Acute Leukemia: A Comparison of Ciprofloxacin with Trimethoprim-Sulfamethoxazole and Colistin A. W. Dekker Annals of Internal Medicine	1987	234
Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome Jan J. Cornelissen, Michael J. Carston, Craig Kollman, Blood	2001	231
Prevention of Infection by Trimethoprim-Sulfamethoxazole Plus Amphotericin B in Patients with Acute Nonlymphocytic Leukaemia A. W. Dekker Annals of Internal Medicine	1981	213
Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group. Bob Löwenberg, Stefan Suciu, E Archimbaud, PubMed	1997	206
Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison Jan J. Cornelissen, Bronno van der Holt, Gregor Verhoef, Blood	2008	179
Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey Dan Engelhard, Catherine Cordonnier, Peter J. Shaw, British Journal of Haematology TransplantationStem Cell TransplantationClinical EpidemiologyTransplantation MedicineClinical Infection	2002	169
Allogeneic Versus Autologous Bone Marrow Transplantation for Refractory and Recurrent Low-Grade Non-Hodgkin's Lymphoma Leo F. Verdonck, A. W. Dekker, Henk M. Lokhorst, Blood	1997	162
Itraconazole Oral Solution for Primary Prophylaxis of Fungal Infections in Patients with Hematological Malignancy and Profound Neutropenia: a Randomized, Double-Blind, Double-Placebo, Multicenter Trial Comparing Itraconazole and Amphotericin B J L Harousseau, A. W. Dekker, Aspasia Stamatoullas‐Bastard, Antimicrobial Agents and Chemotherapy	2000	157

Page 1